Götz Hannelore M, Hoebe Christian J P A, Van Bergen Jan E A M, Veldhuijzen Irene K, Broer Jan, De Groot F, Verhooren M J C, Van Schaik D T, Coenen A J J, Richardus Jan H
Municipal Public Health Service, Rotterdam, The Netherlands.
Sex Transm Dis. 2005 Oct;32(10):625-9. doi: 10.1097/01.olq.0000175397.82962.d5.
We evaluated the management of Chlamydia trachomatis cases and partners found in a systematic home-based chlamydia screening project in the Netherlands among 15- to 29-year-old women and men, organized by the Municipal Public Health Services (MHS).
Infected participants (165/8339 = 2%) were referred to regular curative services. The treating physician provided feedback on treatment and partner notification.
Including the effect of a reminder, the treatment rate of all index cases was 91% (150/165); among persons with non-Dutch ethnicity, 81% (25/31). The majority of cases (82%) consulted the general practitioner for treatment as opposed to sexually transmitted disease/MHS clinics (18%). Eighty-five percent of cases were treated within 2 weeks. The confirmed treatment rate of partners in the last 6 months was 49% (86/176); 57% (81/141) for current versus 14% (5/35) for other partners. Patient referral was advised in an additional 18% (25/141) of current partners and in 9% (3/35) of other partners (potential treatment).
Home-based chlamydia screening and treatment through regular treatment facilities has proven to be effective in the Netherlands. The necessity of a reminder to increase treatment rate and the lower treatment rate in non-Dutch high-risk groups deserve attention. Low confirmed treatment rate of current partners carries the potential of reinfection, and patient-delivered treatment should be expanded.
我们评估了在荷兰由市政公共卫生服务机构（MHS）组织的一项针对15至29岁男女的系统性家庭衣原体筛查项目中发现的沙眼衣原体病例及其性伴侣的管理情况。
感染的参与者（165/8339 = 2%）被转介至常规治疗服务机构。治疗医生提供了关于治疗和性伴侣通知的反馈。
包括提醒的效果在内，所有索引病例的治疗率为91%（150/165）；在非荷兰族裔人群中，治疗率为81%（25/31）。大多数病例（82%）向全科医生咨询治疗，而非性传播疾病/市政公共卫生服务诊所（18%）。85%的病例在2周内接受了治疗。过去6个月中性伴侣的确诊治疗率为49%（86/176）；当前性伴侣的治疗率为57%（81/141），其他性伴侣的治疗率为14%（5/35）。另外有18%（25/141）的当前性伴侣和9%（3/35）的其他性伴侣（潜在治疗对象）被建议由患者转介。
在荷兰，通过常规治疗机构进行家庭衣原体筛查和治疗已被证明是有效的。提高治疗率的提醒的必要性以及非荷兰高危群体中较低的治疗率值得关注。当前性伴侣确诊治疗率低存在再次感染的可能性，应扩大患者自行给药治疗。
